BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0
|
作者：
Kim, M. K. [1 ]
Kim, K. [2 ]
Yoon, D. H. [3 ]
Suh, C. [3 ]
Moon, J. H. [4 ]
Lee, Y. J. [4 ]
Lee, J. H. [5 ]
Jung, S. -H. [6 ]
Kim, H. J. [7 ]
Bae, S. H. [8 ]
Kim, J. S. [9 ]
Lee, J. -O. [10 ]
Eom, H. S. [11 ]
Lee, W. -S. [12 ]
Kang, H. J. [13 ]
Mun, Y. -C. [14 ]
Do, Y. R. [15 ]
Hyun, M. S. [16 ]
机构：
[1] Yeungnam Univ, Coll Med, Internal Med, Daegu, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Seoul, South Korea
[4] Kyungpook Natl Univ Hosp, Daegu, South Korea
[5] Gachon Univ, Gil Hosp, Incheon, South Korea
[6] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
[7] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[8] Catholic Univ, Coll Med Daegu, Daegu, South Korea
[9] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea
[10] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[11] Natl Canc Ctr Korea, Goyang, South Korea
[12] Busan Paik Hosp, Busan, South Korea
[13] Korea Canc Ctr Hosp, Seoul, South Korea
[14] Ewha Womans Univ, Sch Med, Seoul, South Korea
[15] Keimyung Univ, Sch Med, Daegu, South Korea
[16] Yeungnam Univ Hosp, Deagu, South Korea
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1993
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [1] Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma
    Kim, Min Kyoung
    Kim, Kihyun
    Yoon, Do Hyun
    Suh, Cheolwon
    Moon, Joon Ho
    Lee, Yoo Jin
    Lee, Jae Hoon
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Hyo Jung
    Bae, Sung Hwa
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Lee, Won-Sik
    Kang, Hye Jin
    Mun, Yeung-Chul
    Do, Young Rok
    Hyun, Myung Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E70 - E70
  • [2] Bortezomib-Melphalan-Prednisone (VMP) Versus MP As Initial Treatment for Patients Older Than 75 Years with Newly Diagnosed Multiple Myeloma
    Kim, Min Kyoung
    Kim, Kihyun
    Yoon, Dok Hyun
    Suh, Cheolwon
    Lee, Jae Hoon
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Hyo Jung
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Lee, Won Sik
    Mun, Yeung-Chul
    Do, Young Rok
    Kang, Hye Jin
    BLOOD, 2016, 128 (22)
  • [3] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
  • [4] MMY-3002: A phase 3 study comparing bortezomib-melphalan-prednisone (VMP) with melphalan-prednisone (MP) in newly diagnosed multiple myeloma.
    San Miguel, J. F.
    Schlag, R.
    Khuageya, N.
    Shpilberg, O.
    Dimopoulos, M.
    Kropff, M.
    Spicka, L.
    Petrucci, M.
    Sarrioilova, O.
    Dmoszynska, A.
    Abdulkadyrov, K.
    Schots, R.
    Jiang, B.
    Palumbo, A.
    Mateos, M.
    Liu, K.
    Cakana, A.
    Van de Velde, H.
    Richardson, P.
    BLOOD, 2007, 110 (11) : 31A - 31A
  • [5] Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in TransplantIneligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone
    Hou, Jian
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, C. S.
    Rodriguez-Otero, Paula
    Dimopoulos, Meletios A.
    Fujisaki, Tomoaki
    Lee, Jae Hoon
    Wroblewski, Susan
    Carson, Robin
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Bin Jia
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Wang, Jianxiang
    BLOOD, 2021, 138
  • [6] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Dmide
    Cavalli, Maide
    Ria, Roberto
    Gentilini, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Vincelli, Donatella
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Pautasso, Chiara
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Cangialosi, Clotilde
    Mansueto, Giovanna
    Liberati, Anna Marina
    Magarotto, Valeria
    Omede, Paola
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Boccadoro, Mario
    BLOOD, 2012, 120 (21)
  • [7] Oral melphalan, prednisone and lenalidomide treatment for newly diagnosed elderly multiple myeloma patients
    Falco, F.
    MT, Petrucci
    Corradini, P.
    Crippa, C.
    Di Raimondo, F.
    Falcone, A.
    Guiliani, N.
    Musto, P.
    Ruggeri, M.
    Larocca, A.
    D'Agostino, F.
    Canepa, L.
    Gozzetti, A.
    Morabito, F.
    Knight, R.
    Zeldis, J. B.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 31 - 31
  • [8] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
  • [9] Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients
    Palumbo, A.
    Bringhen, S.
    Caravita, T.
    Falcone, A.
    Callea, V.
    Cangialosi, C.
    Grasso, M.
    Galli, M.
    Rossini, F.
    Catalano, L.
    Montanaro, M.
    De Stefano, V.
    Magarotto, V.
    Avonto, I.
    Musto, P.
    Liberati, A. M.
    Cavo, M.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 147 - 147
  • [10] BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT) VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) IN ELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE, RANDOMIZED, PHASE III STUDY
    Palumbo, A.
    Bringhen, S.
    Rossi, D.
    Ria, R.
    Berretta, S.
    Offidani, M.
    Patriarca, F.
    Nozzoli, C.
    Levi, A.
    Guglielmelli, T.
    Benevolo, G.
    Callea, V.
    Liberati, A. M.
    Crippa, C.
    Di Renzo, N.
    Catalano, L.
    De Sabbata, G.
    Rizzi, R.
    Feo, C.
    Mazza, R.
    Farina, G.
    Spadano, A.
    Pisani, F.
    Podda, L.
    Aitoro, G.
    Magarotto, V.
    Astolfi, M.
    Di Raimondo, F.
    Gaidano, G.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 190 - 191
12345